ATE548657T1 - Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie - Google Patents

Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie

Info

Publication number
ATE548657T1
ATE548657T1 AT09151073T AT09151073T ATE548657T1 AT E548657 T1 ATE548657 T1 AT E548657T1 AT 09151073 T AT09151073 T AT 09151073T AT 09151073 T AT09151073 T AT 09151073T AT E548657 T1 ATE548657 T1 AT E548657T1
Authority
AT
Austria
Prior art keywords
polyclonal
cell line
structural characterization
procedure
recombinant
Prior art date
Application number
AT09151073T
Other languages
English (en)
Inventor
Lone Rasmussen
Torben Frandsen
Soren Rasmussen
Peter Andersen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Application granted granted Critical
Publication of ATE548657T1 publication Critical patent/ATE548657T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Document Processing Apparatus (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT09151073T 2004-07-20 2005-07-20 Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie ATE548657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22

Publications (1)

Publication Number Publication Date
ATE548657T1 true ATE548657T1 (de) 2012-03-15

Family

ID=35427551

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05760790T ATE443870T1 (de) 2004-07-20 2005-07-20 Verfahren zur charakterisierung einer polyklonalen zellinie
AT09151073T ATE548657T1 (de) 2004-07-20 2005-07-20 Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05760790T ATE443870T1 (de) 2004-07-20 2005-07-20 Verfahren zur charakterisierung einer polyklonalen zellinie

Country Status (18)

Country Link
US (2) US8288109B2 (de)
EP (2) EP2053408B1 (de)
JP (1) JP4870667B2 (de)
KR (1) KR101319848B1 (de)
AT (2) ATE443870T1 (de)
AU (1) AU2005263334C1 (de)
BR (1) BRPI0513714A (de)
CA (1) CA2574146C (de)
DE (1) DE602005016818D1 (de)
DK (2) DK1787126T3 (de)
ES (2) ES2381531T3 (de)
IL (2) IL180169A (de)
MX (1) MX2007000551A (de)
NO (1) NO20070931L (de)
NZ (1) NZ552264A (de)
PL (2) PL1787126T3 (de)
RU (1) RU2426795C2 (de)
WO (1) WO2006007853A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2512647C (en) 2003-01-07 2013-10-08 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552265A (en) 2004-07-20 2009-04-30 Symphogen As Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
ATE443870T1 (de) 2004-07-20 2009-10-15 Symphogen As Verfahren zur charakterisierung einer polyklonalen zellinie
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
NZ597466A (en) * 2007-03-01 2013-08-30 Symphogen As Recombinant anti-epidermal growth factor receptor antibody compositions
PL2121920T3 (pl) * 2007-03-01 2012-01-31 Symphogen As Sposób klonowania pokrewnych przeciwciał
BRPI0808673A2 (pt) 2007-03-06 2014-08-12 Symphogen A/S Anticorpos recombinantes para tratamento de infecções com vírus sinciciais respiratórios.
CA2680792A1 (en) * 2007-03-15 2008-09-18 Biogen Idec Ma Inc. Treatment of autoimmune disorders
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
CA2683800C (en) 2007-05-25 2015-03-17 Symphogen A/S Method for manufacturing a recombinant polyclonal protein
BRPI0817079A2 (pt) * 2007-09-07 2016-10-11 Symphogen As processos para fabricação recombinante de anticorpos anti-rsv
AU2008328370A1 (en) * 2007-11-22 2009-05-28 Symphogen A/S A method for characterization of a recombinant polyclonal protein
CN102007146A (zh) * 2008-04-23 2011-04-06 西福根有限公司 用于制备多克隆蛋白质的方法
AU2009287165A1 (en) * 2008-08-29 2010-03-04 Symphogen A/S Method for cloning avian-derived antibodies
BRPI0918768B1 (pt) 2008-08-29 2022-08-30 Symphogen A/S Composições de anticorpo recombinante de antireceptor do fator de crescimento epidérmico
US8821879B2 (en) 2009-09-04 2014-09-02 Xoma Technology Ltd. Anti-botulism antibody coformulations
MX2012003538A (es) * 2009-10-09 2012-08-03 Symphogen As Cuantificacion multiple de proteinas recombinantes individuales en una mezcla mediante peptidos distintivos y espectrometria de masas.
CA2796339C (en) * 2010-04-15 2020-03-31 Abbott Laboratories Amyloid-beta binding proteins
EP2635604B1 (de) 2010-11-01 2016-11-30 Symphogen A/S Pan-her-antikörperzusammensetzung
US9790269B2 (en) 2013-02-08 2017-10-17 Misfolding Diagnostics, Inc. Transthyretin antibodies and uses thereof
DK3729958T3 (da) * 2013-03-15 2023-08-07 Mayo Found Medical Education & Res Identificering og overvågning af monoklonale immunoglobuliner ved hjælp af molekylmasse
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
GB201710691D0 (en) * 2017-07-04 2017-08-16 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
CA3104390A1 (en) * 2018-06-22 2019-12-26 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯(重庆)医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法
WO2025038736A1 (en) * 2023-08-15 2025-02-20 Gigagen, Inc. Methods of analyzing recombinant polyclonal proteins

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0162918A1 (de) 1983-11-28 1985-12-04 The Board Of Trustees Of The Leland Stanford Junior University Menschlicher monoklonaler antikörper gegen das antigen rh(d) sowie dessen verwendungen
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
ES2052027T5 (es) 1988-11-11 2005-04-16 Medical Research Council Clonacion de secuencias de dominio variable de inmunoglobulina.
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
PL302438A1 (en) 1992-06-26 1994-07-25 Aetsrn Human anti-rh(d) monoclonal antibodies and cellular lines producing them
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
DE69531148T2 (de) 1994-01-31 2004-04-29 Trustees Of Boston University, Boston Bibliotheken aus polyklonalen antikörpern
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
ES2224255T3 (es) 1996-06-24 2005-03-01 Zlb Behring Ag Polipeptidos capaces de formar estructuras de union a antigenos con especificidad por los antigenos de rhesus d, el dna que los codifica y el proceso para su preparacion y uso.
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) * 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
AU737155B2 (en) 1997-03-14 2001-08-09 Biogen Idec Inc. Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
US6632672B2 (en) 1998-08-19 2003-10-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
CA2379823A1 (en) * 1999-07-16 2001-01-25 Human Genome Sciences, Inc. Real-time, in situ biomanufacturing process monitoring and control in response to ir spectroscopy
EP1234022B1 (de) 1999-07-23 2010-04-07 The Regents Of The University Of California Dna-rekombination in eukaryotischen zellen mittels des rekombinationszentrums vom bakteriophag phic31
EP1106625A1 (de) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D-spezifische Peptidsequenzen
CA2401663C (en) 2000-02-08 2008-11-25 The Regents Of The University Of Michigan Protein mapping
AU2001234880A1 (en) 2000-02-08 2001-08-20 The Regents Of The University Of Michigan Mapping of differential display of proteins
MXPA02007664A (es) 2000-02-08 2004-08-23 Univ Michigan Separacion y representacion de proteinas.
CN1437482A (zh) 2000-05-26 2003-08-20 西福根有限公司 用于治疗变态反应的重组的或纯化的多克隆抗体
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
US20040087014A1 (en) * 2000-11-28 2004-05-06 Huse William D Eukaryotic expression libraries and methods of use
DE60119580T2 (de) * 2000-12-26 2007-04-26 The Institute For Systems Biology, Seattle Schnelle und quantitative proteomanalyse und damit zusammenhängende verfahren
JP4264002B2 (ja) * 2001-07-17 2009-05-13 バイオ−ラド ラボラトリーズ インコーポレイテッド ラテックスベース吸着チップ
GB2385918B (en) * 2001-12-08 2004-05-26 Micromass Ltd Method of mass spectrometry
US20040033591A1 (en) 2002-05-31 2004-02-19 The Regents Of The University Of Michigan Automated protein analysis system
ES2442615T5 (es) * 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi 2次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
WO2004035169A2 (en) 2002-10-15 2004-04-29 The Regents Of The University Of Michigan Multidimensional protein separation system
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
CA2512647C (en) 2003-01-07 2013-10-08 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
NZ552265A (en) 2004-07-20 2009-04-30 Symphogen As Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
ATE443870T1 (de) 2004-07-20 2009-10-15 Symphogen As Verfahren zur charakterisierung einer polyklonalen zellinie
US7850965B2 (en) 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
MX2008011280A (es) 2006-03-06 2008-09-12 Symphogen As Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio.
AU2008328370A1 (en) 2007-11-22 2009-05-28 Symphogen A/S A method for characterization of a recombinant polyclonal protein

Also Published As

Publication number Publication date
ES2381531T3 (es) 2012-05-29
JP4870667B2 (ja) 2012-02-08
KR20070032078A (ko) 2007-03-20
US20130203063A1 (en) 2013-08-08
HK1101043A1 (en) 2007-10-05
AU2005263334A1 (en) 2006-01-26
HK1133076A1 (en) 2010-03-12
AU2005263334C1 (en) 2011-01-20
DK2053408T3 (da) 2012-06-04
DE602005016818D1 (de) 2009-11-05
WO2006007853A2 (en) 2006-01-26
EP1787126A2 (de) 2007-05-23
US9029091B2 (en) 2015-05-12
CA2574146A1 (en) 2006-01-26
ES2332524T3 (es) 2010-02-08
JP2008506960A (ja) 2008-03-06
NO20070931L (no) 2007-04-17
EP1787126B1 (de) 2009-09-23
EP2053408A3 (de) 2009-07-29
PL1787126T3 (pl) 2010-03-31
NZ552264A (en) 2010-03-26
IL180169A0 (en) 2007-06-03
DK1787126T3 (da) 2009-12-21
US8288109B2 (en) 2012-10-16
CA2574146C (en) 2015-06-30
IL203017A (en) 2013-08-29
WO2006007853A3 (en) 2006-05-18
RU2426795C2 (ru) 2011-08-20
IL180169A (en) 2011-04-28
ATE443870T1 (de) 2009-10-15
PL2053408T3 (pl) 2012-08-31
MX2007000551A (es) 2007-03-30
EP2053408A2 (de) 2009-04-29
EP2053408B1 (de) 2012-03-07
AU2005263334B2 (en) 2010-08-05
BRPI0513714A (pt) 2008-05-13
RU2007106050A (ru) 2008-08-27
KR101319848B1 (ko) 2013-10-18
US20080131882A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
ATE548657T1 (de) Prozedur zur strukturellen charakterisierung rekombinanter polyclonaler proteine oder einer polyclonalen zelllinie
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
EA201590631A1 (ru) Антигенсвязывающие белки, способные связывать тимусный стромальный лимфопоэтин
ATE512987T1 (de) Verfahren zur in-vitro-diagnose von alzheimer- krankheit mit einem monoklonalen antikörper
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
NO922457L (no) Antistoffantagonister av humant interleukin-4
EP2534257A4 (de) Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden
WO2003060090A3 (en) Novel cytokine zcytor17 ligand
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
LV10284A (lv) Epitelija sunu augsanas faktoru specifiski kodejosa DNS
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
ATE447180T1 (de) Verfahren zur vorbehandlung von proben sowie immuntestverfahren unter dessen verwendung
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
DE60140346D1 (de) System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
DE60333669D1 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
ATE521896T1 (de) Verfahren und mittel zur bestimmung von definierten zuständen oder veränderungen in der uterusschleimhaut oder im epithel anderer organe
BR0315565A (pt) Método para se obter uma linhagem celular de mamìfero adaptada para crescer em meio livre de soro e proteìna, linhagem celular de mamìfero, uso do método, anticorpos humanizados contra o receptor de egf hr3 ou seus fragmentos, contra o antìgeno cd6 t1ht ou seus fragmentos, e contra o antìgeno cd3 t3q ou seus fragmentos
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
WO2024011061A3 (en) Compositions and methods to detect autoimmune antibodies
EP1627323A4 (de) Albumin-bindestellen zur bewertung von medikamentenwechselwirkungen und verfahren zur bewertung oder entwicklung von medikamenten auf der basis ihrer albumin-bindeeigenschaften
WO2003061575A3 (en) Anti-idiotype antibody of disintegrin and uses thereof